Your browser doesn't support javascript.
loading
A hepatic sparganosis misdiagnosed as intrahepatic mass-forming cholangiocarcinoma: a case report and literature review.
Wang, Yinjiao; Lou, Yu; Chen, Lang; Yang, Xin; Cao, Aihong; Du, Peng.
Affiliation
  • Wang Y; Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Lou Y; Department of Radiology, The 71st Group Army Hospital of the People's Liberation Army of China, Xuzhou, China.
  • Chen L; Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Yang X; Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Cao A; Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Du P; Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Front Oncol ; 14: 1391256, 2024.
Article in En | MEDLINE | ID: mdl-38660131
ABSTRACT
Hepatic sparganosis (HS) is extremely rare and has not been previously reported in Eastern China. We report the diagnosis and treatment of a patient with HS from Xuzhou City, Jiangsu Province, China. The patient was admitted due to an acute biliary tract infection, and the symptoms improved after treatment at the Gastroenterology Department. During an ultrasound examination on admission, an abnormal echo was incidentally discovered at the junction of the left and right lobes of the liver. Thereafter, upper abdominal computed tomography (CT) and magnetic resonance imaging (MRI) non-contrast and contrast-enhanced examinations, and serum tumor biomarker examination were completed. After a multidisciplinary treatment (MDT) discussion at the Department of Hepatobiliary Surgery, the patient was diagnosed with intrahepatic mass-type cholangiocarcinoma (IMCC) and surgery was recommended. The patient underwent surgical treatment, and postoperative pathology revealed HS. No signs of intrahepatic recurrence were observed during the 1-year follow-up period.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2024 Document type: Article Affiliation country: China Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2024 Document type: Article Affiliation country: China Country of publication: Switzerland